SCHEMBL861355

SCHEMBL861355

CCCCCNc1nc(C)c(Cc2ccc(OCCCN3CCCC3)cc2)c(N)n1

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 16/20 0.56
HRH3 Q9Y5N1 3/20 0.48
HRH4 Q9H3N8 1/20 0.45
LTA4H P09960 1/20 0.45
TLR8 Q9NR97 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853436 0.96 TLR7 (0.54) TLR7LTA4H
SCHEMBL861830 0.94 TLR7 (0.60) TLR7HRH3TLR8
SCHEMBL853780 0.86 DHFR (0.58) TLR7LTA4H
SCHEMBL855086 0.85 DHFR (0.47) TLR7TLR8
SCHEMBL3702171 0.85 TLR7 (0.75) TLR7TLR8
SCHEMBL861371 0.85 DHFR (0.57) TLR7LTA4H
SCHEMBL853213 0.83 TLR7 (0.57) TLR7TLR8
SCHEMBL854804 0.83 TLR7 (0.55) TLR7LTA4HTLR8
SCHEMBL3709605 0.81 TLR7 (0.73) TLR7TLR8
SCHEMBL854178 0.81 ALDH1A1 (0.51) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed